Research Article
BibTex RIS Cite

Awareness and rates of vaccination in hemodialysis patients

Year 2023, , 283 - 287, 30.08.2023
https://doi.org/10.47582/jompac.1324097

Abstract

Aims: Vaccination is main risk reducing strategy for vaccine-preventable infections in chronic kidney disease (CKD) patients, but vaccination rates in hemodialysis patients are not at the desired level. In this study, we aimed to search the rates of influenza, pneumococcal, hepatitis B and coronavirus disease-2019 (COVID-19) vaccination, the vaccination awareness and the reasons for not taking vaccination in hemodialysis patients.
Methods: In this cross-sectional study, 232 CKD patients undergoing hemodialysis in two centers for at least six months were included. The patients completed the questionnaire about vaccination. The data about patients’ history of vaccination regarding influenza, pneumococcal, hepatitis B and COVID-19 vaccines; patients’ attitudes and knowledge about vaccination; the source of information about vaccination were collected via this questionnaire.
Results: The rates of pneumococcal, influenza, hepatitis B and COVID-19 vaccination were 9.9%, 56.6%, 38.8% and 87.1%, respectively. In patients with missing vaccination, the main reasons for not taking vaccination were lack of knowledge about vaccination (48.7%), the thought that the vaccine is not beneficial (12.5%) and fear of adverse effects (3.4%). The main sources of information about vaccination were healthcare workers (90.5%), radio/televison (1.7%) and internet (1.7%).
Conclusion: Our findings showed that the rates of influenza, pneumococcal and hepatitis B vaccination were below the targeted levels and the main reason was the lack of information about vaccination and the main source of information about vaccination was health personnel. Strategies should be developed to increase the awareness and rate of vaccination for vaccine-preventable infections in CKD patients.

References

  • Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease:global dimension and perspectives. Lancet. 2013;382(9888):260–272.
  • Reddy S, Chitturi C, Yee J. Vaccination in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):72-78.
  • Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23(4):437–447.
  • Babu TM, Kotton CN. Immunizations in chronic kidney disease and kidney transplantation. Curr Treat Options Infect Dis. 2021;13(2):47-65.
  • Kidney Disease:Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
  • Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 Vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412-1423.
  • Moore LR, Al-Jaddou N, Wodeyar H, et al. SARS-CoV-2 in dialysis patients and the impact of vaccination. BMC Nephrol. 2022;23(1):317.
  • Yıldız Y, Telatar TG, Baykal M, Aykanat Yurtsever B, Yıldız İE. COVID-19 pandemisi döneminde aşı reddinin değerlendirilmesi. DÜ Sağlık Bil Enst Derg. 2021;11(2):200-205.
  • Günay E, Kaya, Ş, Yüksel E. The Blind Spot On Hemodialysis:Vaccination. Turk Bull Hygiene Exper Biol. 2020;77(2):149-154.
  • Tan HZ, Phang CC, Wu SY, et al. Improving influenza and pneumococcal vaccination uptake among incident peritoneal dialysis patients:a quality improvement initiative. Int Urol Nephrol. 2021;53(10):2167-2175.
  • Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD), Adult Immunization Guide (2019). Available from: https://www.ekmud.org.tr/emek/rehberler/1-ekmud-rehberleri.
  • World Health Organization, “Global vaccine action plan 2011-2020” 2013. Available from:https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/global-vaccine-action-plan.
  • Mutlu A, Şengül E, Boz G. A cross-sectional survey study on influenza and pneumococcal vaccination rates and the factors affecting vaccination rates in hemodialysis patients in Kocaeli Province of Turkey. Ther Apher Dial. 2022;26(3):640-648.
  • Akinbodewa AA, Gbadegesin BA, Adejumo OA, et al. A multicentre study of awareness and practice of vaccination against infectious diseases among haemodialysis subjects in Nigeria. West Afr J Med. 2019;36(3):239-245.
  • Tharwat S, Khairallah MK, Nassar MK, Nassar DK, Nagy E. Acceptance of COVID-19 vaccination among maintenance hemodialysis patients:an Egyptian survey study. Trop Med Health. 2022;50(1):42.
  • Wallace H, Mount PF. COVID-19 beliefs and vaccination uptake in dialysis patients:lessons from an anonymous patient survey. Intern Med J. 2022;52(9):1488-1494.

Hemodiyaliz hastalarında aşılanma oranları ve farkındalığı

Year 2023, , 283 - 287, 30.08.2023
https://doi.org/10.47582/jompac.1324097

Abstract

Amaçlar: Aşılanma, kronik böbrek hastalığı (KBH) olan hastalarda aşı ile önlenebilir enfeksiyonlar için ana risk azaltma stratejisidir, ancak hemodiyaliz hastalarında aşılanma oranları istenilen düzeyde değildir. Bu çalışmada influenza, pnömokok, hepatit B ve koronavirüs hastalığı-2019 (COVID-19) aşılanma oranları, aşı farkındalığı ve aşı yaptırmama nedenlerini araştırmayı amaçladık.
Yöntemler: Bu kesitsel çalışmaya iki merkezde en az altı aydır hemodiyaliz tedavisi gören 232 KBH hastası dahil edildi. Hastalar aşılanma ile ilgili anketi doldurdu. Hastaların influenza, pnömokok, hepatit B ve COVID-19 aşılarına dair aşılanma geçmişlerine ilişkin veriler; hastaların aşılanma konusundaki tutumları ve bilgileri; aşılanma ile ilgili bilgilerin kaynağı bu anket aracılığıyla toplandı.
Bulgular: Pnömokok, influenza, hepatit B ve COVID-19 aşılanma oranları sırasıyla %9,9, %56,6, %38,8 ve %87,1 idi. Aşı yaptırmayan hastalarda bunun başlıca nedenlerinin aşı hakkında bilgi sahibi olmama (%48,7), aşının faydalı olmadığı düşüncesi (%12,5) ve yan etki korkusu (%3,4) olduğu görüldü. Aşı ile ilgili başlıca bilgi kaynakları sağlık çalışanları (%90,5), radyo/televizyon (%1,7) ve internet (%1,7) idi.
Sonuç: Bulgularımız, influenza, pnömokok ve hepatit B aşılanma oranlarının hedeflenen seviyelerin altında olduğunu ve bunun temel nedeninin aşılar hakkında bilgi eksikliği olduğunu ve aşılanma ile ilgili başlıca bilgi kaynağının sağlık personeli olduğunu göstermiştir. KBH hastalarında aşı ile önlenebilir enfeksiyonlara yönelik farkındalığı ve aşılanma oranını artıracak stratejiler geliştirilmelidir.

References

  • Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease:global dimension and perspectives. Lancet. 2013;382(9888):260–272.
  • Reddy S, Chitturi C, Yee J. Vaccination in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):72-78.
  • Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23(4):437–447.
  • Babu TM, Kotton CN. Immunizations in chronic kidney disease and kidney transplantation. Curr Treat Options Infect Dis. 2021;13(2):47-65.
  • Kidney Disease:Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
  • Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 Vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412-1423.
  • Moore LR, Al-Jaddou N, Wodeyar H, et al. SARS-CoV-2 in dialysis patients and the impact of vaccination. BMC Nephrol. 2022;23(1):317.
  • Yıldız Y, Telatar TG, Baykal M, Aykanat Yurtsever B, Yıldız İE. COVID-19 pandemisi döneminde aşı reddinin değerlendirilmesi. DÜ Sağlık Bil Enst Derg. 2021;11(2):200-205.
  • Günay E, Kaya, Ş, Yüksel E. The Blind Spot On Hemodialysis:Vaccination. Turk Bull Hygiene Exper Biol. 2020;77(2):149-154.
  • Tan HZ, Phang CC, Wu SY, et al. Improving influenza and pneumococcal vaccination uptake among incident peritoneal dialysis patients:a quality improvement initiative. Int Urol Nephrol. 2021;53(10):2167-2175.
  • Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD), Adult Immunization Guide (2019). Available from: https://www.ekmud.org.tr/emek/rehberler/1-ekmud-rehberleri.
  • World Health Organization, “Global vaccine action plan 2011-2020” 2013. Available from:https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/global-vaccine-action-plan.
  • Mutlu A, Şengül E, Boz G. A cross-sectional survey study on influenza and pneumococcal vaccination rates and the factors affecting vaccination rates in hemodialysis patients in Kocaeli Province of Turkey. Ther Apher Dial. 2022;26(3):640-648.
  • Akinbodewa AA, Gbadegesin BA, Adejumo OA, et al. A multicentre study of awareness and practice of vaccination against infectious diseases among haemodialysis subjects in Nigeria. West Afr J Med. 2019;36(3):239-245.
  • Tharwat S, Khairallah MK, Nassar MK, Nassar DK, Nagy E. Acceptance of COVID-19 vaccination among maintenance hemodialysis patients:an Egyptian survey study. Trop Med Health. 2022;50(1):42.
  • Wallace H, Mount PF. COVID-19 beliefs and vaccination uptake in dialysis patients:lessons from an anonymous patient survey. Intern Med J. 2022;52(9):1488-1494.
There are 16 citations in total.

Details

Primary Language English
Subjects Nefroloji
Journal Section Research Articles [en] Araştırma Makaleleri [tr]
Authors

Raziye Yazıcı

İbrahim Güney

Atila Yürekli

Selver Can

Publication Date August 30, 2023
Published in Issue Year 2023

Cite

AMA Yazıcı R, Güney İ, Yürekli A, Can S. Awareness and rates of vaccination in hemodialysis patients. J Med Palliat Care / JOMPAC / Jompac. August 2023;4(4):283-287. doi:10.47582/jompac.1324097

images?q=tbn:ANd9GcRrI_RWgGRe7JRpz3PAnkt2YEFD2l6WEmgHMzuM2w9b&s

f9ab67f.png     

7yziemq.png




COPE.jpg

icmje_1_orig.png

cc.logo.large.png

ncbi.png

ORCID_logo.png

images?q=tbn:ANd9GcQk2AsOdjP67NBkYAqd8FHwCmh0_3dkMrXh3mFtfPKXwIai7h0lIds8QYM9YjKMhZw8iP0&usqp=CAU

logo_world_of_journals_no_margin.png1280px-WorldCat_logo.svg.png                             images?q=tbn:ANd9GcRrI_RWgGRe7JRpz3PAnkt2YEFD2l6WEmgHMzuM2w9b&s


Dergimiz; TR-Dizin ULAKBİM, ICI World of  Journal's, Index Copernicus, Directory of Research Journals Indexing (DRJI), General Impact Factor, Google Scholar, Researchgate, WorldCat (OCLC), CrossRef (DOI), ROAD, ASOS İndeks, Türk Medline İndeks, Eurasian Scientific Journal Index (ESJI) ve Türkiye Atıf Dizini'nde indekslenmektedir.

EBSCO, DOAJ, OAJI, ProQuest dizinlerine müracaat yapılmış olup, değerlendirme aşamasındadır.

Makaleler "Çift-Kör Hakem Değerlendirmesi”nden geçmektedir.

Üniversitelerarası Kurul (ÜAK) Eşdeğerliği: Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN].

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser.  About predatory/questionable journals and journal charge policy

Not: Dergimiz WOS indeksli değildir ve bu nedenle Q  sınıflamasına dahil değildir.
Yağmacı/şüpheli dergilerle ilgili Yüksek Öğretim Kurumu (YÖK) kararları ve yazar açıklama metni ile dergi ücret politikası: Yağmacı/Şaibeli Dergiler ve Dergi Ücret Politikası